Telitacicept in combination with standard therapy was effective for the treatment of systemic lupus erythematosus through 52 weeks.

The following transcript is automatically generated and may contain typos or misspellings. Please listen to the episode for the most accurate language. Dr. Susan Manzi 0:00 Hello everyone. I'm Dr.

Like in other chronic inflammatory disorders, achieving disease activity control in SLE requires the application of the treat-to-target strategy. This approach requires setting clear treatment targets ...

Long-term use of glucocorticoids (GCs) for the treatment of lupus is very common, however, it has also been associated with side effects like high blood pressure, diabetes, infection, and osteoporosis ...

In systemic lupus erythematosus, chronic spontaneous urticaria did not raise SLEDAI scores, but cylindruria, mucosal ulcers, ...

H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on Gracell Biotechnologies (GRCL – Research Report) today and set a price target of $13.00. Emily Bodnar’s Buy rating for Gracell ...

Please provide your email address to receive an email when new articles are posted on . Patients with systemic lupus with a history of skin rashes are likely to have high interferon levels. This ...

The "US Systemic Lupus Erythematosus Market and Competitive Landscape – 2021" report has been added to ResearchAndMarkets.com’s offering. The latest research US Systemic Lupus Erythematosus Market and ...

(MENAFN- EIN Presswire) EINPresswire/ -- Get 20% Off All Global Market Reports With Code ONLINE20 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors How Much Is The Systemic ...

A Phase II study was subsequently performed by the LBSL02/99 group, which enrolled 449 patients who met American College of Rheumatology (ACR) diagnostic criteria for SLE, had active SLE disease and ...

It is my view that B-cell therapy will likely become an important part of the treatment paradigm in SLE over the next 3–5 years. I think the data are suitably strong to justify the approval of ...